Published in
Springer Verlag, Clinical Pharmacokinetics, 10(55), p. 1171-1177
DOI: 10.1007/s40262-016-0394-3
Links
Tools
How ‘Optimal’ are Optimal Sampling Times for Tyrosine Kinase Inhibitors in Cancer? Practical Considerations
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 